LRNASH SMELLING SALTS- ammonium carbonate granule

LRNASH SMELLING SALTS by

Drug Labeling and Warnings

LRNASH SMELLING SALTS by is a Otc medication manufactured, distributed, or labeled by Shenzhen Tie Gou Li Trading Co., Ltd.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

Ammonium Carbonate 15%

PURPOSE

Reflex stlmulant

INDICATIONS & USAGE

Uses To prevent or treat fainting,enhancealertness

WARNINGS

Keep away from the Eyes.
For external use only.
Stop use and ask a doctor if condition persists.

DO NOT USE

lf face is flush
in or near the eyes
lf you have breathing problems such as asthma or emphysema.

WHEN USING

Keep away from the Eyes,
For external use only.

STOP USE

Patient is non-responsive
condition lasts

KEEP OUT OF REACH OF CHILDREN

If swallowed, get medical help or contact a Poison Control Center right away.1-800-222-1222

DOSAGE & ADMINISTRATION

Adults and children 12 years of age and older.
Hold the bottle 6 inches away from yournose,take a quick gentle sniff.
Close the cap tightly after each use.

INACTIVE INGREDIENT

Silica Silylate
Sea Salt
Ammonium Hydroxide
Carbonic Acid
Ammonium Fluorosilicate

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

LRNASH SMELLING SALTS 
ammonium carbonate granule

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 85405-001
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
AMMONIUM CARBONATE (UNII: NJ5VT0FKLJ) (AMMONIUM CATION - UNII:54S68520I4)	AMMONIUM CARBONATE	15 g  in 100 g

Inactive Ingredients
Ingredient Name	Strength
AMMONIUM HEXAFLUOROSILICATE (UNII: 1X545W620G)
SEA SALT (UNII: 87GE52P74G)
AMMONIA (UNII: 5138Q19F1X)
CARBON DIOXIDE (UNII: 142M471B3J)
SILANAMINE (UNII: DO19I45F4L)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 85405-001-01	1 in 1 BOX	03/24/2025
1		50 g in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	505G(a)(3)	03/24/2025

Labeler - Shenzhen Tie Gou Li Trading Co., Ltd. (453766025)

Establishment
Name	Address	ID/FEI	Business Operations
Shenzhen Tie Gou Li Trading Co., Ltd.		453766025	manufacture(85405-001)